![](/img/cover-not-exists.png)
PCN6 PRESERVED ANTITUMOR ACTIVITY AND REDUCED CARDIOTOXICITY OF FIRST-LINE PEGYLATED LIPOSOMAL DOXORUBICIN COMPARED WITH CONVENTIONAL DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST CANCER
K Mann, C Rana, A WadhwaVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71903-9
File:
PDF, 78 KB
english, 2010